| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.25 | 2e-05 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.29 | 2e-05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.22 | 0.0009 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.21 | 0.001 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.18 | 0.007 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.17 | 0.03 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.12 | 0.07 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.1 | 0.1 |